Document:

Exhibit
      10.1

    AGREEMENT
      TO AMEND SERIES J WARRANTS

    OF
      WUHAN GENERAL GROUP (CHINA), INC.

    
 

    THIS
      AGREEMENT TO AMEND THE SERIES J WARRANTS (this
      “Agreement”), effective as of September 5, 2008, by and among Wuhan General
      Group (China), Inc. (the “Company”) and the Holders of Warrants who submit a
      signature page hereto, amend and restate the Series J Warrants, dated as of
      February 7, 2007 (the “Original Form of Series J Warrants”).

    

    WITNESSETH

     

    WHEREAS,
      the Company issued the Series J Warrants to investors on February 7,
      2007;

     

    WHEREAS,
      the parties hereto desire to amend the Original Form of Series J Warrants in
      accordance with the terms and conditions hereinafter set forth;

     

    NOW,
      THEREFORE,
      in
      consideration of good and valuable consideration, the receipt and sufficiency
      of
      which are hereby acknowledged, the undersigned hereby agree as
      follows:

     

    1. Amendment
      and Restatement of the Series J Warrants.
      The
      Original Form of Series J Warrants is hereby amended and restated in the form
      attached hereto as Exhibit
      A
      (the
“Amended and Restated Form of Series J Warrants”).

    

    2 Replacement
      Warrants.
      Upon the
      return by each Series J Warrant Holder of its originally issued Series J
      Warrant, the Company agrees promptly to execute and deliver to such Series
      J
      Warrant Holder a replacement warrant in the Amended and Restated Form of Series
      J Warrant. Notwithstanding any delay in the exchange of the replacement warrant
      for the original warrant, the amendment and restatement contained herein shall
      become effective on the date of this Agreement.

    

    3 Filing
      of Certificate of Designation of Series B Convertible Preferred
      Stock.
      Upon the
      execution and delivery of this Agreement, the Company shall file promptly with
      the Nevada Secretary of State the Certificate of Designation of the Relative
      Rights and Preferences of the Series B Convertible Preferred Stock in the form
      attached hereto as Exhibit
      B.

    

    4 Construction.
      Capitalized
      terms used in this Agreement and not defined herein shall have the meanings
      ascribed to them in the Amended and Restated Form of Series J
      Warrants.

     

    5. Headings.
      The
      headings and other captions in this Agreement are for convenience and reference
      only and shall not be used in interpreting, construing or enforcing any
      provision of this Agreement.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    6. Governing
      Law.
      The
      internal laws, and not the laws of conflicts, of New York shall govern the
      enforceability and validity of this Agreement, the construction of its terms
      and
      the interpretation of the rights and duties of the parties.

     

    7. Counterparts.
      This
      Agreement may be executed in any number of counterparts (including by facsimile)
      and by different parties hereto in separate counterparts, with the same effect
      as if all parties had signed the same document. All such counterparts shall
      be
      deemed an original, shall be construed together and shall constitute one and
      the
      same instrument.

     

     

    [Remainder
      of page intentionally left blank.]

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF,
      the
      undersigned have caused this Agreement to be executed, all as of the day and
      year first written above.

     

    
      	 	 	 
	 	WUHAN
              GENERAL
              GROUP (CHINA), INC.
	 
 	 
 	 
 
	 	By:  	/s/ Xu
              Jie
	 	
              Name:
                Xu Jie

              Title:
                President and Chief Executive Officer

            
	 	 

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
      	 	 	 
	 	
              In accordance with Section 11 of the Original
                Form of
                Series J Warrants, the undersigned, being Holders of Warrants exercisable
                for a majority of the shares of Warrant Stock issuable under the
                Warrants,
                hereby consent to the Company’s entry into this Agreement to Amend Series
                J Warrants.

            
	 	 
	 	 
	 	 
	 	VISION OPPORTUNITY MASTER FUND, LTD.
	 
 	 
 	 
 
	 	By:  	/s/ Adam
              Benowitz
	 	
              Name:
                Adam Benowitz

              Title:
                Director

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
      	 	 	 
	 	BLUE
              RIDGE INVESTMENTS, L.L.C.
	 
 	 
 	 
 
	 	By:  	/s/ Yongmei
              Shen 
	 	
              Name:
                Yongmei Shen 

              Title:
                Vice President 

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

    
      	
            	 	 
	 	OLD
              LANE CAYMAN MASTER FUND, L.P.
	 
 	 
 	 
 
	 	By:  	/s/ Steven
              Weiss 
	 	
              
                Name:
                  Steven Weiss 

                Title:
                  Director of Operations 

              

            

      	
            	 	 
	 	OLD
              LANE US MASTER FUND, L.P.
	 
 	 
 	 
 
	 	By:  	/s/ Steven
              Weiss 
	 	
              
                Name:
                  Steven Weiss 

                Title:
                  Director of Operations 

              

            

    

     

    
      	
            	 	 
	 	OLD
              LANE HMA MASTER FUND, L.P.
	 
 	 
 	 
 
	 	By:  	/s/ Steven
              Weiss 
	 	
              
                Name:
                  Steven Weiss 

                Title:
                  Director of OperationsCONSULTING
      AGREEMENT FOR INTERIM CEO SERVICES

    

    

    This
      Agreement is made effective as of September 07, 2008, by and between Power3
      Medical, Products, Inc., of 3400 Research Forest Dr., The Woodlands, Texas
      77381, and Bronco Technology, Inc., of P O Box 30, Huntsville, Texas 77342-0030.
      

    

    In
      this Agreement Power3 Medical Products, Inc. (hereinafter Power3) is contracting
      to receive the services of Helen R. Park, CEO of Bronco Technology, Inc.
      (hereinafter BTI) as Interim CEO of Power3 Medical Products, Inc. The services
      are described below.

    

    Helen
      R. Park has a background in biotechnology business consulting, planning, and
      reorganization and is willing to provide services to Power3 through BTI based
      on
      this background.

    

    Power3
      desires to have services provided by Helen R. Park through
      BTI.

    

    Therefore,
      the parties agree as follows:

    

    1.
      DESCIPTION
      OF SERVICES.
      Beginning on September 08, 2008, BTI will provide the following services
      (collectively, the “Services”): Helen R. Park will serve as Interim CEO for
      Power3, reporting to the Board of Directors of Power3, on a consulting basis,
      providing business planning, reorganization, management and marketing
      services.

    

    2.
      PERFORMANCE
      OF SERVICES.
      Power3 will rely on Helen R. Park to work as many hours as may be reasonably
      necessary to fulfill BTI’s obligations under this
      agreement.

    

    3.
      PAYMENT.
      Power3 will pay a fee to BTI for the Services of $5,000.00 per month. This
      fee
      shall be payable monthly, no later than the last day of the month following
      the
      period during which the Services were performed; Subject to an anticipated
      increase in the authorized common shares of Power3 BIT will also receive 100,000
      shares of the Company’s restricted common stock per month.

    

    4.
      COMMISSION
      PAYMENTS.
      In addition to the payments under the preceding paragraph Power3 will make
      commission payments to BTI based on Milestones of progress made in marketing
      company product and services to be mutually agreed upon at a later
      date.

    

    a.
      Payment Schedule.
      The commission payments shall be payable monthly, no later than the last day
      of
      the following month.

    

    b.
      Accounting.
      Power3 shall maintain records in sufficient detail for purposes of determining
      the amount of commission. Power3 shall provide to BTI a written accounting
      that
      sets forth the manner in which the commission payment was
      calculated.

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    c.
      Right to Inspect.
      BTI, or BTI’s agent, shall have the right to inspect Power3’s records for the
      limited purpose of verifying the calculation of the commission payments, subject
      to such restrictions as Power3 may reasonably impose to protect the
      confidentially of the records. Such inspections shall be made during reasonable
      business hours as may be set by Power3.

    

    d.
      Death or Disability.
      If Helen R. Park dies or becomes disabled and unable to perform the services,
      during the term of this Agreement, BTI shall be entitled to payments or partial
      commission for the period ending when the services are no longer able to be
      carried out by Helen R. Park.

    

    5.
      EXPENSE
      REIMBURSEMENT.
      BTI shall be entitled to reimbursement from Power3 for the following expenses:
      travel expenses, meals, excluding alcoholic beverages, postage, copying, and
      others as approved by Power3.

    

    6.
      SUPPORT
      SERVICES.
      Power3 will provide the following support services for the benefit of BTI:
      office space; use of staff and secretarial support; and office
      supplies.

    

    7.
      TERM/TERMINATION.
      This agreement may be terminated by either party upon 30 days written notice
      to
      the other party.

    

    8.
      REALTIONSHIP
      OF PARTIES.
      It is understood by the parties that BTI is an independent contractor with
      respect to Power3, and not an employee of Power3. Power3 will not provide fringe
      benefits, including health insurance benefits, paid vacation, or any other
      employee benefit, for the benefit of BTI.

    

    9.
      DISCLOSURE.
      BTI is required to disclose any outside activities or interests, including
      ownership or participation in the development of prior invention, that conflict
      or may conflict with the best interest of Power3. Prompt disclosure is required
      under this paragraph if the activity or interest is related, directly or
      indirectly, to:

    

    -
      any intellectual property of Power3

    -
      a product or product line of Power3

    -
      a manufacturing process of Power3

    -
      any activity that BTI may be involved with on behalf of
      Power3

    

    10.
      EMPLOYEES. BTI
      employees, if any, who perform services for Power3 under this Agreement shall
      also be bound by the provision of this Agreement.

    

    11.
      INTELLECTUAL
      PROPERTY.
      The following provision shall apply with respect to copyrightable works, ideas,
      discoveries, inventions, applications for patents, and patents (collectively,
      “Intellectual Property”):

    

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    a.
      Development of Intellectual Property.
      Any inventions or improvements, and any new items of Intellectual Property
      discovered or developed by BTI (or BTI’s employees, if any) during the term of
      this Agreement shall be the property of Power3. BTI shall sign all documents
      necessary to perfect the rights of Power3 in such Intellectual Property,
      including the filing and/or prosecution of any applications for copyrights
      or
      patents. Upon request, BTI shall sign all documents necessary to assign the
      rights to such Intellectual Property to Power3.

    

    12.
      CONFIDENTIALITY.
      Power3 recognizes that BTI has and will have access to proprietary information
      (collectively, “Information”) which are valuable, special and unique assets of
      Power3 Medical, Inc. and need to be protected from improper disclosure. In
      consideration for the disclosure of Information, BTI agrees that BTI will not
      at
      any time or in any manner, either directly or indirectly, use any Information
      for BTI’s own benefit, or divulge, disclose, or communicate in any manner any
      Information to any third party without the prior written consent of Power3.
      BTI
      will protect the Information and treat it as strictly confidential. A violation
      of this paragraph shall be a material violation of this
      Agreement.

    

    13.
      UNAUTHORIZED
      DISCLOSURE OF INFORMATION.
      If it appears that BTI has disclosed (or has threatened to disclose) Information
      in violation of this Agreement, Power3 shall be entitled to an injunction to
      restrain BTI from disclosing, in whole or in part, such Information, or from
      providing any services to any party to whom such Information has been disclosed
      or may be disclosed. Power3 shall not be prohibited by this provision from
      pursuing other remedies, including a claim for losses and
      damages.

    

    14.
      CONFIDENTLIALITY
      AFTER TERMINATION.
      The confidentiality provisions of this Agreement shall remain in full force
      and
      effect after the termination of this Agreement.

    

    15.
      RETURN
      OF RECORDS.
      Upon termination of this Agreement, BTI shall deliver all records, notes, data,
      memoranda, models, and equipment of any nature that are in BTI’s possession or
      under BTI’s control and that are Power3’s property or relate to Power3’s
      business.

    

    16.
      NOTICES.
      All notices required or permitted under this Agreement shall be in writing
      and
      shall be deemed delivered when delivered in person or deposited in the United
      States mail, postage prepaid, addressed as follows:

    

    

    If
      for Power3:

    

    Power3
      Medical Products, Inc.

    Ira
      Goldknopf

    President
      & Chief Scientific Officer

    3400
      Research Forest Dr.

    The
      Woodlands, Texas 77381

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    If
      for BIT:

    

    Bronco
      Technology, Inc.

    Helen
      R. Park

    CEO

    P.O.
      Box 30 

    Huntsville,
      Texas 77342-0030

    

    Such
      address may be changed from time to time by either party by providing written
      notice to the other in the manner set forth above.

    

    17.
      ENTIRE
      AGREEMENT.
      This Agreement contains the entire agreement of the parties and there are no
      other promises or conditions n any other agreement whether oral or written.
      This
      Agreement supersedes any prior written or oral agreements between the
      parties.

    

    18.
      AMENDMENT.
      This Agreement may be modified or amended if the amendment is made in writing
      and is signed by both parties.

    

    19.
      SERVERABILITY.
      If any provision of this Agreement shall be held to be invalid or unenforceable
      for any reason, the remaining provisions shall continue to be valid and
      enforceable. If a court finds that any provision of this agreement is invalid
      or
      unenforceable, but that by limiting such provision it would become valid and
      enforceable, then such provision shall be deemed to be written, construed,
      and
      enforce as so limited.

    

    20.
      WAIVER
      OF CONTRACTUAL RIGHT.
      The failure of either part to enforce any provision of this Agreement shall
      not
      be construed as a waiver or limitation of that party’s right to subsequently
      enforce and compel strict compliance with every provision of this
      Agreement.

    

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    21.
      APPLICABLE
      LAW.
      This Agreement shall be governed by the laws of the State of Texas.

    

       

    
      	
              Power3
                Medical Products, Inc.

            	
              Bronco
                Technology, Inc.

            
	 	 
	 	 
	
              By:
                /s/ Ira L.
                Goldknopf          
                

            	
              By:
                /s/ Helen R.
                Park               
                

            
	
              Ira
                L. Goldknopf

            	
              Helen
                R. Park

            
	
              President
                and Chief Scientific Officer

            	
              CEO

            

    

    

    
      
         

      

      
        5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]